Juvena’s lead drug discovery Scientist, Dr. Thach Mai, gave an excellent lecture, “Mapping Secreted Proteins to Unmet Medical Needs” to graduate students at Maastricht Centre for Systems Biology (MaCSBio). Dr. Mai outlined Juvena’s use of machine learning and computational tools to unravel the therapeutic potential of stem cell-secreted human proteins
Juvena CEO, Hanadie Yousef, Explores the Future of the Intersection of Technology and Biology Alongside Silicon Valley Entrepreneurs with Middle East & Northern African roots at the Annual TechWadi Forum
Discussing longevity insights among financial and biotech leaders at the BioFuture Conference, Juvena CEO, Hanadie Yousef, PhD explores the role of secreted proteins in targeting chronic and age-related diseases.
Juvena’s CSO, Dr. O’Connell, was an invited speaker at the 6th Annual Fibrotic Drug Discovery Summit in Nov. 2022 and discussed how decoding stem cell secreted proteins can enable drug discovery for fibrotic degenerative diseases, providing an overview of Juvena’s pulmonary and hepatic programs.
Juvena Therapeutics is recognized for its transformative science that targets unmet medical needs as well as for the quality of its management team as part of the Emerging Company Showcase at the prestigious Life Sciences Summit.
Juvena CEO, Hanadie Yousef, PhD, discusses the market opportunity for their unique discovery platform for mapping secreted proteins to unmet medical needs leading to their growing pipeline of biologics for rare and chronic diseases to senior leaders of Mubadala’s LP.